Allakos announces first-time patient administration in phase 1 trial of AK006 for chronic spontaneous urticaria
Allakos宣布在慢性自发性荨麻疹的Ak006的1期试验中首次给药患者
Allakos announces first-time patient administration in phase 1 trial of AK006 for chronic spontaneous urticaria
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.